Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q4 2021
- Shares held
- 15.0M
- −1.48M (−9.0%) vs. Q4 2021
- Total value
- $8.42M
- −$3.25M (−27.9%) vs. Q4 2021
- New holders
- 3
- 9 more added
- Sold out
- 6
- 14 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $34.7M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,822,193 | $1.58M | 0.00% | −215,296−7.1% | Reduced |
| Menora Mivtachim Holdings Ltd. | 2,094,208 | $1.17M | 0.02% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,950,949 | $1.09M | 0.59% | +20,857+1.1% | Added |
| American Financial Group Inc | 1,480,000 | $829.0K | 0.25% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $659.0K | 0.01% | 00.0% | Unchanged |
| Altshuler Shaham Ltd | 1,088,848 | $609.0K | 0.01% | −68,692−5.9% | Reduced |
| Geode Capital Management, LLC | 800,333 | $448.0K | 0.00% | +2,275+0.3% | Added |
| Nantahala Capital Management, LLC | 774,767 | $434.0K | 0.03% | −119,892−13.4% | Reduced |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $328.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 501,583 | $280.0K | 0.00% | −6,552−1.3% | Reduced |
| Bridgeway Capital Management, LLC | 309,400 | $173.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 233,400 | $131.0K | 0.00% | −234,600−50.1% | Reduced |
| State Street Corp | 189,959 | $106.0K | 0.00% | +7,956+4.4% | Added |
| Vanguard Capital Wealth Advisors | 158,900 | $86.0K | 0.06% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 146,291 | $82.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 123,669 | $69.0K | 0.00% | −700−0.6% | Reduced |
| Atom Investors LP | 113,151 | $63.0K | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 105,883 | $59.0K | 0.00% | −69,681−39.7% | Reduced |
| Group One Trading, L.P. | 78,896 | $44.0K | 0.00% | +34,124+76.2% | Added |
| Bank of America Corp | 58,213 | $32.0K | 0.00% | +40,990+238.0% | Added |
| Wells Fargo & Company | 46,672 | $26.0K | 0.00% | +20.0% | Added |
| B. Riley Wealth Management, Inc. | 37,500 | $21.0K | 0.00% | −11,000−22.7% | Reduced |
| Meeder Asset Management Inc | 28,531 | $16.0K | 0.00% | +28,531 | New |
| Two Sigma Investments, LP | 23,079 | $13.0K | 0.00% | −94,650−80.4% | Reduced |
| D. E. Shaw & Co., Inc. | 21,295 | $12.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 21,849 | $12.0K | 0.00% | +21,849 | New |
| Virtu Financial LLC | 20,504 | $11.0K | 0.00% | −109,766−84.3% | Reduced |
| Jane Street Group, LLC | 20,354 | $11.0K | 0.00% | +20,354 | New |
| Advisor Group Holdings, Inc. | 13,359 | $8.00K | 0.00% | +1,000+8.1% | Added |
| Susquehanna International Group, LLP | 11,860 | $7.00K | 0.00% | −22,792−65.8% | Reduced |
| Morgan Stanley | 5,632 | $3.00K | 0.00% | +1,941+52.6% | Added |
| Tower Research Capital LLC (TRC) | 1,539 | $1.00K | 0.00% | −8,057−84.0% | Reduced |
| BNP Paribas Arbitrage, SA | 489 | $274 | 0.00% | −158−24.4% | Reduced |
| Simplex Trading, LLC | 764 | $0 | 0.00% | −42,434−98.2% | Reduced |
| JPMorgan Chase & Co | 622 | $0 | 0.00% | +581+1,417.1% | Added |
| National Bank of Canada | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −553,652−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −29,492−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −26,072−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,350−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,499−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,791−100.0% | Sold out |